Allen Lu, MBA, PMP
Associate Director, Global Development PMO at Regeneron- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Agatha Lee
Allen is a fast learning, smart and energetic researcher. He is always filled with great creative ideas. He has a great people skill and down to earth characteristics. It was really fun and rejoicing to work with him.
Agatha Lee
Allen is a fast learning, smart and energetic researcher. He is always filled with great creative ideas. He has a great people skill and down to earth characteristics. It was really fun and rejoicing to work with him.
Agatha Lee
Allen is a fast learning, smart and energetic researcher. He is always filled with great creative ideas. He has a great people skill and down to earth characteristics. It was really fun and rejoicing to work with him.
Agatha Lee
Allen is a fast learning, smart and energetic researcher. He is always filled with great creative ideas. He has a great people skill and down to earth characteristics. It was really fun and rejoicing to work with him.
Credentials
-
Creative Facilitation
Lucid SoftwareJun, 2023- Nov, 2024 -
Whiteboarding Foundations
Lucid SoftwareJun, 2023- Nov, 2024 -
Collaborative Leadership
Schwartz and AssociatesNov, 2021- Nov, 2024 -
Prosci® Certified Change Practitioner
ProsciSep, 2021- Nov, 2024 -
Business Process Improvement
LinkedInAug, 2021- Nov, 2024 -
Change Management Foundations
LinkedInAug, 2021- Nov, 2024 -
Leading Remote Projects and Virtual Teams
LinkedInAug, 2021- Nov, 2024 -
Project Leadership
LinkedInAug, 2021- Nov, 2024 -
Critical Thinking
LinkedInJul, 2021- Nov, 2024
Experience
-
Regeneron
-
United States
-
Biotechnology
-
700 & Above Employee
-
Associate Director, Global Development PMO
-
Mar 2022 - Present
-
-
Consultant, Global Development PMO
-
Aug 2021 - Mar 2022
-
-
-
MESO SCALE DIAGNOSTICS, LLC.
-
Biotechnology Research
-
500 - 600 Employee
-
Senior Project Manager
-
Apr 2016 - Aug 2021
• Led the successful development, commercialization, and launch of MSD’s COVID-19 Serology Panels which was chosen by Operation Warp Speed (OWS) as its standard assays for immunogenicity assessments in OWS funded Phase III clinical trials of vaccines; managed all aspects of the accelerated program from concept to delivery. • Works with the executive team to translate corporate goals into implementable project plans; engages and aligns cross-functional teams to bring new products to… Show more • Led the successful development, commercialization, and launch of MSD’s COVID-19 Serology Panels which was chosen by Operation Warp Speed (OWS) as its standard assays for immunogenicity assessments in OWS funded Phase III clinical trials of vaccines; managed all aspects of the accelerated program from concept to delivery. • Works with the executive team to translate corporate goals into implementable project plans; engages and aligns cross-functional teams to bring new products to market. • Directly responsible for the success of MSD’s most complex, high impact, and time sensitive programs; new product launches include V-PLEX panels, S-PLEX ultra-sensitive platform, and 500+ immunoassays and their integration with MSD’s instruments and software platforms. • Leads MSD’s overall new product portfolio to drive consumables business growth. ✔ Stakeholder Management. Engages and aligns stakeholders from all levels; integrates their input into project planning and ensures expectations are met throughout the project life cycle. ✔ Schedule Management. Develops and executes integrated cross-functional plans and schedules while balancing priorities and resources across multiple departments and programs. ✔ Risk Management. Proactively identifies and mitigates risks; works directly with team members and senior managers to anticipate issues, solve problems, and take decisive actions to minimize impact. ✔ Decision Management. Integrates differing points of view to understand issues, proposes options, and guides project and senior management teams to make high-quality decisions to drive the program forward. ✔ Quality Management. Ensures projects are executed under Design Change Control and in compliance with established Quality Management Systems and regulatory standards. • Built MSD’s project management function; hired and managed a team of project managers. • Implements and drives process improvements to consistently deliver projects on time.
-
-
Project Manager
-
Jun 2013 - Apr 2016
• Successfully launched multiple assay products including V-PLEX multiplex panels, U-PLEX development platform, U-PLEX assays, R-PLEX assays, and MSD GOLD products. • Managed projects in accordance with MSD’s phase-gated and regulated process for assay development, which includes feasibility, development, verification, and validation phases. • Assembled and maintained complex project plans, schedules, and resource allocations for MSD’s consumables development pipeline;… Show more • Successfully launched multiple assay products including V-PLEX multiplex panels, U-PLEX development platform, U-PLEX assays, R-PLEX assays, and MSD GOLD products. • Managed projects in accordance with MSD’s phase-gated and regulated process for assay development, which includes feasibility, development, verification, and validation phases. • Assembled and maintained complex project plans, schedules, and resource allocations for MSD’s consumables development pipeline; simultaneously managing 6-8 high priority projects. • Led cross-functional project team to deliver projects according to project and program plans; utilized collaborative and creative problem solving skills to mitigate project risks and schedule delays. • Worked closely with technical development teams and effectively coordinated design transfer activities between Research & Development, Operations and Quality. • Coordinated communications with all project stakeholders and routinely presented to executive management with detailed project status.
-
-
Research Associate
-
Jul 2010 - Jun 2013
Led the development of cytokine and biomarker immunoassays in coordination with a cross-functional project team. Independently designed, planned, and executed complex assay development protocols; consistently completed deliverables ahead of schedule. Created automated tools for data analysis and uniform templates for data presentation.
-
-
-
Medtronic
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Business Development Intern
-
Jun 2012 - Aug 2012
Gained practical experience in international business development in coordination with the Global Technology Entrepreneurship Fellowship. Gained practical experience in international business development in coordination with the Global Technology Entrepreneurship Fellowship.
-
-
-
Pathogenica, Inc.
-
Cambridge, Massachusetts, United States
-
Assay Development Scientist
-
May 2010 - Jul 2010
Advanced commercial applications of next-generation DNA sequencing as a medical diagnostic for rapid and low cost identification of microbes and viruses in clinical samples. Successfully optimized technology from proof of concept to scalable platform for commercialization. Advanced commercial applications of next-generation DNA sequencing as a medical diagnostic for rapid and low cost identification of microbes and viruses in clinical samples. Successfully optimized technology from proof of concept to scalable platform for commercialization.
-
-
-
Harvard Medical School
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Fellow, NIH National Research Service Award Fellowship
-
Mar 2008 - May 2010
Research. Investigated the role of endoplasmic reticulum stress in diabetes and obesity for the development of therapeutic treatments. Utilized mammalian cell culture and in vivo mouse models to better understand the molecular mechanisms of insulin and leptin resistance. Experienced in design of experiments, development and execution of complex protocols, and statistical data analysis. • PCR Design & Optimization • DNA Isolation & Purification • Mammalian Cell… Show more Research. Investigated the role of endoplasmic reticulum stress in diabetes and obesity for the development of therapeutic treatments. Utilized mammalian cell culture and in vivo mouse models to better understand the molecular mechanisms of insulin and leptin resistance. Experienced in design of experiments, development and execution of complex protocols, and statistical data analysis. • PCR Design & Optimization • DNA Isolation & Purification • Mammalian Cell Culture • Adeno & Lentiviral Production • RNAi Gene Silencing • Protein Isolation & Purification • Immunoprecipitation • SDS-PAGE Electrophoresis • Western Blotting • ELISA Immunoassay • RNA Isolation & Purification • Quantitative Real-Time PCR • in vivo Mouse Models Management. Managed a fast-paced collaborative laboratory conducting translational research in endocrinology. Worked directly with research and administrative staff to maintain efficient lab operations. • Provided technical and application support in troubleshooting protocols and equipment • Trained laboratory assistants, technicians, research fellows, and students in laboratory techniques • Maintained lab and BL2+ tissue culture facility in regulatory compliance with chemical and biological safety • Organized and presented research at division seminars and group meetings to multidisciplinary audiences • Prepared technical reports of research findings for journal publications and conference presentations • Assisted in writing and budgeting of grants from institutional and national funding agencies Show less Research. Investigated the role of endoplasmic reticulum stress in diabetes and obesity for the development of therapeutic treatments. Utilized mammalian cell culture and in vivo mouse models to better understand the molecular mechanisms of insulin and leptin resistance. Experienced in design of experiments, development and execution of complex protocols, and statistical data analysis. • PCR Design & Optimization • DNA Isolation & Purification • Mammalian Cell… Show more Research. Investigated the role of endoplasmic reticulum stress in diabetes and obesity for the development of therapeutic treatments. Utilized mammalian cell culture and in vivo mouse models to better understand the molecular mechanisms of insulin and leptin resistance. Experienced in design of experiments, development and execution of complex protocols, and statistical data analysis. • PCR Design & Optimization • DNA Isolation & Purification • Mammalian Cell Culture • Adeno & Lentiviral Production • RNAi Gene Silencing • Protein Isolation & Purification • Immunoprecipitation • SDS-PAGE Electrophoresis • Western Blotting • ELISA Immunoassay • RNA Isolation & Purification • Quantitative Real-Time PCR • in vivo Mouse Models Management. Managed a fast-paced collaborative laboratory conducting translational research in endocrinology. Worked directly with research and administrative staff to maintain efficient lab operations. • Provided technical and application support in troubleshooting protocols and equipment • Trained laboratory assistants, technicians, research fellows, and students in laboratory techniques • Maintained lab and BL2+ tissue culture facility in regulatory compliance with chemical and biological safety • Organized and presented research at division seminars and group meetings to multidisciplinary audiences • Prepared technical reports of research findings for journal publications and conference presentations • Assisted in writing and budgeting of grants from institutional and national funding agencies Show less
-
-
-
David Geffen School of Medicine at UCLA
-
United States
-
Higher Education
-
700 & Above Employee
-
Graduate Student Researcher
-
Jun 2004 - Dec 2006
Investigated brain structural abnormalities in HIV/AIDS patients in collaboration with the University of Pittsburgh. Used quantitative 3D MRI-based models and statistical analysis to identify the selective patterns of brain atrophy in relation to cognitive impairment and immune system deterioration. Investigated the effects of childhood-onset schizophrenia (COS) on adolescent brain development in collaboration with the National Institute of Mental Health. Used tensor-based morphometry… Show more Investigated brain structural abnormalities in HIV/AIDS patients in collaboration with the University of Pittsburgh. Used quantitative 3D MRI-based models and statistical analysis to identify the selective patterns of brain atrophy in relation to cognitive impairment and immune system deterioration. Investigated the effects of childhood-onset schizophrenia (COS) on adolescent brain development in collaboration with the National Institute of Mental Health. Used tensor-based morphometry to map growth pattern abnormalities throughout the brain. Applied multidimensional statistical analysis to reveal significantly slower white matter growth rates in COS patients compared to healthy controls; also studied the growth rate differences in correlation with clinical symptoms and functional outcomes. Show less Investigated brain structural abnormalities in HIV/AIDS patients in collaboration with the University of Pittsburgh. Used quantitative 3D MRI-based models and statistical analysis to identify the selective patterns of brain atrophy in relation to cognitive impairment and immune system deterioration. Investigated the effects of childhood-onset schizophrenia (COS) on adolescent brain development in collaboration with the National Institute of Mental Health. Used tensor-based morphometry… Show more Investigated brain structural abnormalities in HIV/AIDS patients in collaboration with the University of Pittsburgh. Used quantitative 3D MRI-based models and statistical analysis to identify the selective patterns of brain atrophy in relation to cognitive impairment and immune system deterioration. Investigated the effects of childhood-onset schizophrenia (COS) on adolescent brain development in collaboration with the National Institute of Mental Health. Used tensor-based morphometry to map growth pattern abnormalities throughout the brain. Applied multidimensional statistical analysis to reveal significantly slower white matter growth rates in COS patients compared to healthy controls; also studied the growth rate differences in correlation with clinical symptoms and functional outcomes. Show less
-
-
-
The National Institutes of Health
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Postbaccalaureate Research Fellow
-
Jun 2006 - Sep 2006
Developed an automated biological image processing method to allow high-throughput processing of large patient databases. Trained research assistants in various biological imaging methods. Organized a large database of structural MRI volumes leading to longitudinal investigations on brain development. Developed an automated biological image processing method to allow high-throughput processing of large patient databases. Trained research assistants in various biological imaging methods. Organized a large database of structural MRI volumes leading to longitudinal investigations on brain development.
-
-
-
UCLA
-
United States
-
Higher Education
-
700 & Above Employee
-
Laboratory Assistant
-
Jun 2003 - Jun 2004
Designed and constructed a high-throughput pulse laser ablation system for implementation in catalytic nanoparticle formation useful in the discovery of novel catalysts. Confirmed the successful formation of uniformly sized nanoparticles on catalytic supports using transmission electron microscopy. Designed and constructed a high-throughput pulse laser ablation system for implementation in catalytic nanoparticle formation useful in the discovery of novel catalysts. Confirmed the successful formation of uniformly sized nanoparticles on catalytic supports using transmission electron microscopy.
-
-
Education
-
Harvard Medical School
NIH National Research Service Award Fellowship -
University of Maryland - Robert H. Smith School of Business
MBA, Innovation and Technology -
University of California, Los Angeles
MS, Biomedical Engineering -
University of California, Los Angeles
BS, Chemical Engineering -
Technion - Israel Institute of Technology
Global Technology Entrepreneurship Fellowship